Originally developed to help manage Type 2 diabetes, GLP-1 receptor agonists have become widely known for their effectiveness in helping patients lose weight
The berry sweetness masks any protein powder chalkiness without spiking blood sugar
While genetic testing does not predict exact medication response, it can help providers understand metabolic predispositions and support more informed conversations about whether GLP-1 is a good clinical fit for a particular patient
J Cardiovasc Dev Dis
While clinical trials demonstrate substantial average weight loss, achieving optimal results requires proper dosing, adequate treatment duration, and comprehensive lifestyle modifications
Research by Vanduchova et al., 2019, highlights the distinct biological activities of SFN enantiomers, with the natural (R)-SFN showing significantly greater efficacy compared to the (S)-SFN enantiomer